drugset / Trial / NCT04733157

The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section

NCT04733157 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

This study seeks to determine if the using tranexamic acid prophylactically at caesarean section will prevent postpartum haemorrhage which is a major cause of maternal mortality in Zimbabwe and globally.

Timeline

Start
2021-03-23
Primary completion
2021-12-14
Completion
2021-12-14

Outcome

Missed primary endpoint

registry analysis (other test); Study Group/Group A_(Tranexamic Acid) vs Control Group/Group B_(Placebo); p = 0.33; Risk Ratio (RR) 0.87 (95% CI 0.69 to 1.09) NCT04733157 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.